Inhibitory Effect of Gliclazide on Platelet Adhesiveness and Aggregation in Alloxan Diabetic Rabbits
Open Access
- 1 January 1979
- journal article
- research article
- Published by Pharmaceutical Society of Japan in YAKUGAKU ZASSHI
- Vol. 99 (1) , 59-64
- https://doi.org/10.1248/yakushi1947.99.1_59
Abstract
The inhibitory effect of gliclazide, a new sulfonylurea, on platelet function was examined in alloxan diabetic rabbits. The blood glucose level in diabetic rabbits was about 3 .times. higher than in normal rabbits, and the plasma insulin level was below 50% of that of normal rabbits. Platelet adhesiveness to glass beads and platelet aggregation by collagen were markedly enhanced in the diabetic rabbits. Administration 2-4 wk daily of gliclazide (100 mg/kg, orally) to diabetic rabbits effected the reduction of enhanced platelet adhesiveness, and platelet aggregation was also lowered to that of normal rabbits after 4 wk. Blood glucose and plasma insulin levels were not changed by the treatment. Gliclazide may exert an inhibitory action on platelet function via mechanism(s) other than insulin secretion and glucose metabolism.Keywords
This publication has 5 references indexed in Scilit:
- INCREASED SENSITIVITY OF INVIVO PLATELET-AGGREGATION IN RABBITS AFTER ALLOXAN OR STREPTOZOTOCIN1976
- Platelet adhesiveness in diabetes mellitusJournal of Clinical Pathology, 1967
- The colorimetric micro-determination of long-chain fatty acidsBiochemical Journal, 1963
- Simple Rapid Microtechnic for Serum Total CholesterolAmerican Journal of Clinical Pathology, 1957
- Ineffectiveness of Sulfonylureas in Alloxan Diabetic Rats.Experimental Biology and Medicine, 1956